New Breast Cancer Screening Device Detects Malignant Tumors Instantly

Cancer Connect

A new minimally invasive screening device called the Smart Probe can instantly detect cancerous tissue, according to the Lawrence Livermore National Laboratory.

The Smart Probe consists of a small needle equipped with multiple sensors and is intended for use as a diagnostic tool after initial screening. After a mammogram indicates an area of concern, the Smart Probe is inserted into breast tissue and the sensors measure optical, electrical and chemical properties. The Smart Probe can then distinguish between healthy and cancerous tissue based on the differences in these properties.

The Smart Probe works in real time, gathering information and communicating it to software that interprets it and instantly displays results on a computer screen. Click here and get More Info WebDesign499. These instant results provide information that helps physicians to decide whether more invasive and costly tests are necessary. In addition, patients have immediate access to their results, which can relieve anxiety and help them to make medical decisions.

The Smart Probe may allow for earlier and more accurate detection of breast cancer. It is a minimally invasive procedure that does not remove any tissue. The Smart Probe has the potential to diagnose breast cancer without surgery, and, as a result, may help to decrease the number of unnecessary biopsies and reduce health care costs.

The Smart Probe is based on technology originally developed by NASA researchers and is currently being developed by the Lawrence Livermore National Laboratory and BioLuminate, Inc. The first human clinical trials utilizing the Smart Probe are expected to begin this spring in Northern California. The Smart Probe is expected to be available for commercial use by 2003.

The upcoming clinical trials will help to determine the feasibility of using the Smart Probe as a standard diagnostic tool. Women who are at a high-risk for developing breast cancer may wish to speak with their physicians about the risks and benefits of participating in a clinical trial in which the Smart Probe and other promising new screening techniques are being evaluated. Two sources of information about ongoing clinical trials include clinical trials listing services provided by the National Cancer Institute ( and also performs personalized clinical trial searches on behalf of patients. (Lawrence Livermore National Laboratory Press Release)

Copyright © 2018 CancerConnect. All Rights Reserved.